{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:41:34Z","timestamp":1785415294581,"version":"3.56.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T00:00:00Z","timestamp":1242172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1546-0096-7-9","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T19:29:13Z","timestamp":1242242953000},"source":"Crossref","is-referenced-by-count":104,"title":["Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases"],"prefix":"10.1186","volume":"7","author":[{"given":"Kirk","family":"Sperber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Peng","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,13]]},"reference":[{"key":"362_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/rheumatology\/36.7.799","volume":"36","author":"RI Rynes","year":"1997","unstructured":"Rynes RI: Antimalarial drugs in the treatment of rheumatic diseases. Br J Rheumatol. 1997, 36: 799-805. 10.1093\/rheumatology\/36.7.799.","journal-title":"Br J Rheumatol"},{"key":"362_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev.bi.55.070186.003311","volume":"55","author":"I Mellman","year":"1986","unstructured":"Mellman I, Fuchs R, Helerius A: Acidification of the endocytic and exocytic pathways. Annu Rev Biochem. 1986, 55: 663-700. 10.1146\/annurev.bi.55.070186.003311.","journal-title":"Annu Rev Biochem"},{"key":"362_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1042\/bj2400739","volume":"240","author":"K Oda","year":"1986","unstructured":"Oda K, Kariyama Y, Yomada E, Ikahara Y: Effects of weakly basic amines on proteolytic processing and terminal glycosylation of secretory proteins in rat hepatocytes. Biochem J. 1986, 240: 739-745.","journal-title":"Biochem J"},{"key":"362_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ncprheum0292","volume":"1","author":"D Kyburg","year":"2006","unstructured":"Kyburg D, Bretano F, Gay S: Mode of action of Hydroxychloroquine in RA-evidence of an inhibiting effect on toll-like receptor signaling. Nat Clin Pract Rheumatol. 2006, 1: 458-459. 10.1038\/ncprheum0292.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"362_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/art.21039","volume":"52","author":"BJ Fessler","year":"2005","unstructured":"Fessler BJ, Alarcon GS, McGwin G, Roseman J, Bastian HM, Friedman AW, the LUMINA study group: Systemic lupus erythematosus in three ethnic groups. XVI. Association of Hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 2005, 52: 1473-1480. 10.1002\/art.21039.","journal-title":"Arthritis Rheum"},{"key":"362_CR6","first-page":"1349","volume":"9","author":"P Emery","year":"2003","unstructured":"Emery P, Suarez-Almazor M: Rheumatoid arthritis. Clin Evid. 2003, 9: 1349-1371.","journal-title":"Clin Evid"},{"key":"362_CR7","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2165\/00002018-200629100-00003","volume":"29","author":"F Vroom","year":"2006","unstructured":"Vroom F, de Walle HE, Laar van de MA, Brouwers JR, Berg de Jong-van den LT: Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future. Drug Saf. 2006, 29: 845-63. 10.2165\/00002018-200629100-00003.","journal-title":"Drug Saf"},{"key":"362_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.semarthrit.2005.05.002","volume":"35","author":"KK Temprano","year":"2005","unstructured":"Temprano KK, Bandlamudi R, Moore T: Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum. 2005, 35: 112-21. 10.1016\/j.semarthrit.2005.05.002.","journal-title":"Semin Arthritis Rheum"},{"key":"362_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archotol.1964.00750040419009","volume":"80","author":"CW Hart","year":"1964","unstructured":"Hart CW, Naunton RF: The ototoxicity of chloroquine phosphate. Arch Otolaryngol. 1964, 80: 407-412.","journal-title":"Arch Otolaryngol"},{"key":"362_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/00003495-200767010-00006","volume":"67","author":"RM Santaella","year":"2007","unstructured":"Santaella RM, Fraunfelder FW: Ocular adverse effects associated with systemic medications: recognition and management. Drugs. 2007, 67: 75-93. 10.2165\/00003495-200767010-00006.","journal-title":"Drugs"},{"key":"362_CR11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/art.1780310904","volume":"31","author":"FJ Stafford-Brady","year":"1988","unstructured":"Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M: Lupus retinopathy: patterns, associations, and prognosis. Arthritis Rheum. 1988, 31: 1105-1110. 10.1002\/art.1780310904.","journal-title":"Arthritis Rheum"},{"key":"362_CR12","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/art.10150","volume":"46","author":"N Costedoat-Chalumeau","year":"2002","unstructured":"Costedoat-Chalumeau N, Amoura Z, Aymard G, Le TH, Wechsler B, Vauthier D, Dermer ME, Darbois Y, Piette JC: Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum. 2002, 46: 1123-4. 10.1002\/art.10150.","journal-title":"Arthritis Rheum"},{"key":"362_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1957","volume":"8","author":"M Ostensen","year":"2006","unstructured":"Ostensen M, Khamashta M, Lockshin M, Parke A: Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Research and Therapy. 2006, 8: 1-19. 10.1186\/ar1957.","journal-title":"Arthritis Research and Therapy"},{"key":"362_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","volume":"4","author":"N Costedoat-Chalumeau","year":"2005","unstructured":"Costedoat-Chalumeau N, Amoura Z, Huong DL, Lechat P, Piette JC: Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev. 2005, 4: 111-5. 10.1016\/j.autrev.2004.11.009.","journal-title":"Autoimmun Rev"},{"key":"362_CR15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2165\/00002018-200124140-00004","volume":"24","author":"MB Borden","year":"2001","unstructured":"Borden MB, Parke AL: Antimalarial drugs in systemic lupus erythematosus: use in pregnancy. Drug Saf. 2001, 24: 1055-63. 10.2165\/00002018-200124140-00004.","journal-title":"Drug Saf"},{"issue":"Suppl 1","key":"362_CR16","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1177\/096120339600500114","volume":"5","author":"MA Khamashta","year":"1996","unstructured":"Khamashta MA, Buchanan NM, Hughes GR: The use of hydroxychloroquine in lupus pregnancy: the British experience. Lupus. 1996, 5 (Suppl 1): S65-6. 10.1177\/096120339600500114.","journal-title":"Lupus"},{"key":"362_CR17","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000, 283: 2008-12. 10.1001\/jama.283.15.2008.","journal-title":"JAMA"},{"key":"362_CR18","volume-title":"Systematic reviews in health care: meta-analysis in context","year":"2002","unstructured":"Egger M, Smith GD, Altman DG, eds: Systematic reviews in health care: meta-analysis in context. 2002, BMJ Books: London, 2","edition":"2"},{"key":"362_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","volume":"6","author":"SH Downs","year":"1998","unstructured":"Downs SH, Black N: The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions. J Epidemiol Community Health. 1998, 6: 377-84. 10.1136\/jech.52.6.377.","journal-title":"J Epidemiol Community Health"},{"key":"362_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","volume":"146","author":"BA Martell","year":"2007","unstructured":"Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten RD, Fiellin FA: Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction. Ann Intern Med. 2007, 146: 116-127.","journal-title":"Ann Intern Med"},{"key":"362_CR21","unstructured":"Review Manager (RevMan) [computer program]. Version 4.2 for Windows. 2003, Copenhagen: The Nordic Centre"},{"key":"362_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Liard N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"key":"362_CR23","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JA: A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006, 25: 3443-57. 10.1002\/sim.2380.","journal-title":"Stat Med"},{"key":"362_CR24","volume-title":"Systematic Reviews and Healthcare: meta-analysis in context","author":"JJ Deeks","year":"2002","unstructured":"Deeks JJ, Altman DG, Bradburn MJ: Statistical methods for examining heterogeneity and combing results from several studies in a meta-analysis. Systematic Reviews and Healthcare: meta-analysis in context. Edited by: Egger M, Davey Smith G, Altman DG. 2002, London BMJ Publications"},{"key":"362_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analysis. BMJ. 2003, 327: 577-560. 10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"key":"362_CR26","first-page":"65","volume-title":"Designing clinical research","author":"SB Hully","year":"2001","unstructured":"Hully SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB: Designing clinical research. 2001, Philadelphia: Lipponcott Williams, and Wilkens, 65-91. 2","edition":"2"},{"key":"362_CR27","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1002\/art.22159","volume":"54","author":"ME Clowse","year":"2006","unstructured":"Clowse ME, Magder L, Witter F, Petri M: Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006, 54: 3640-3647. 10.1002\/art.22159.","journal-title":"Arthritis Rheum"},{"key":"362_CR28","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1002\/art.11304","volume":"48","author":"N Costedoat-Chalumeau","year":"2003","unstructured":"Costedoat-Chalumeau N, Amoura Z, Duhaut P, Huong DL, Sebbough D, Wechsler B, Vauthier D, Denjoy I, Lupoglazoff JM, Piette JC: Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum. 2003, 48: 3207-11. 10.1002\/art.11304.","journal-title":"Arthritis Rheum"},{"key":"362_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/ard.55.7.486","volume":"55","author":"NM Buchanan","year":"1996","unstructured":"Buchanan NM, Toubi E, Khamashta MA, Lima F, Kerslake S, Hughes GR: Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis. 1996, 55: 486-468. 10.1136\/ard.55.7.486.","journal-title":"Ann Rheum Dis"},{"key":"362_CR30","first-page":"755","volume":"13","author":"M Frassi","year":"2004","unstructured":"Frassi M, Biasini C, Taglieti M, Daneli E: Hydroxychloroquine in pregnant patients with rheumatic disease: a case control observation of 76 treated pregnancies. Lupus. 2004, 13: 755-","journal-title":"Lupus"},{"key":"362_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1191\/096120301678646137","volume":"10","author":"RA Levy","year":"2001","unstructured":"Levy RA, Vilela VS, Cataldo MJ, Ramos RC, Duarte JL, Tura BR, Albuquerque EM, Jesus NR: Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus. 2001, 10: 401-404. 10.1191\/096120301678646137.","journal-title":"Lupus"},{"key":"362_CR32","first-page":"87","volume-title":"Systematic reviews to support evidence-based medicine","author":"KS Khan","year":"2003","unstructured":"Khan KS, Kunz R, Kleijnen J, Antes G: Systematic reviews to support evidence-based medicine. 2003, London: Royal Society of Medicine Press, 87-96."},{"key":"362_CR33","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/2271257a0","volume":"227","author":"S Ulberg","year":"1970","unstructured":"Ulberg S, Lindquist NG, Sjostrand SE: Accumulation of chorioretinotoxic drugs in the foetal eye. Nature. 1970, 227: 1257-1258. 10.1038\/2271257a0.","journal-title":"Nature"},{"key":"362_CR34","doi-asserted-by":"crossref","unstructured":"Garner P, G\u00fclmezoglu AM: Drugs for preventing malaria in pregnant women. Cochrane Database of Systematic Reviews. 2006, CD000169-4","DOI":"10.1002\/14651858.CD000169.pub2"},{"key":"362_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/sj.jp.7211208","volume":"25","author":"M Motta","year":"2005","unstructured":"Motta M, Tincani A, Faden D, Zinzini E, Lojacono A, Marchesi A, Frassi M, Biasini C, Zatti S, Chirico G: Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol. 2005, 25: 86-9. 10.1038\/sj.jp.7211208.","journal-title":"J Perinatol"},{"key":"362_CR36","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(02)07643-2","volume":"359","author":"M Motta","year":"2002","unstructured":"Motta M, Tincani A, Faden D, Zinzini E, Chirico G: Antimalarial agents in pregnancy. Lancet. 2002, 359: 524-5. 10.1016\/S0140-6736(02)07643-2.","journal-title":"Lancet"},{"key":"362_CR37","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(01)06004-4","volume":"358","author":"G Klinger","year":"2001","unstructured":"Klinger G, Morad Y, Westall CA, Laskin C, Spitzer KA, Koren G, Ito S, Buncic RJ: Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet. 2001, 358: 813-4. 10.1016\/S0140-6736(01)06004-4.","journal-title":"Lancet"},{"key":"362_CR38","first-page":"1715","volume":"23","author":"A Parke","year":"1996","unstructured":"Parke A, West B: Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol. 1996, 23: 1715-8.","journal-title":"J Rheumatol"},{"key":"362_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1055\/s-2007-999371","volume":"8","author":"M Levy","year":"1991","unstructured":"Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G: Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol. 1991, 8: 174-178. 10.1055\/s-2007-999371.","journal-title":"Am J Perinatol"},{"key":"362_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/archderm.1983.01650270003003","volume":"119","author":"Suhonen","year":"1983","unstructured":"Suhonen: Hydroxychloroquine administration in pregnancy. Arch Dermatol. 1983, 119: 185-6. 10.1001\/archderm.119.3.185a.","journal-title":"Arch Dermatol"},{"key":"362_CR41","first-page":"732","volume":"13","author":"M Petri","year":"1994","unstructured":"Petri M: Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am. 1994, 13: 732-739.","journal-title":"Rheum Dis Clin North Am"},{"key":"362_CR42","first-page":"508","volume-title":"Dubois's lupus erthymatosus","author":"RC Kitridou","year":"1992","unstructured":"Kitridou RC, Mintz G: The fetus in systemic lupus erythematous. Dubois's lupus erthymatosus. Edited by: Wallace DJ, Hahn BH. 1992, Philadelphia: Lea and Febiger, 508-515. 4","edition":"4"},{"key":"362_CR43","first-page":"732","volume":"13","author":"G Mintz","year":"1986","unstructured":"Mintz G, Niz J, Guttierez G, Garcia Alonso A, Karchmer S: Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986, 13: 732-739.","journal-title":"J Rheumatol"},{"key":"362_CR44","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0307-742X(21)00607-X","volume":"11","author":"MD Lockshin","year":"1985","unstructured":"Lockshin MD: Lupus pregnancy. Clin Rheum Dis. 1985, 11: 611-632.","journal-title":"Clin Rheum Dis"},{"key":"362_CR45","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/0002-9343(84)90538-2","volume":"77","author":"MD Lockshin","year":"1984","unstructured":"Lockshin MD, Reinitz E, Druzin ML, Murrman M, Este D: Lupus pregnancy case-control prospective study demonstrate absence of lupus exacerbation during or after pregnancy. Am J Med. 1984, 77: 893-888. 10.1016\/0002-9343(84)90538-2.","journal-title":"Am J Med"},{"key":"362_CR46","first-page":"650","volume":"20","author":"M Petri","year":"1993","unstructured":"Petri M, Allbritton J: Fetal outcome of lupus pregnancy: A retrospective case-controlled study of the Hopkins lupus cohort. J Rheumatol. 1993, 20: 650-666.","journal-title":"J Rheumatol"},{"key":"362_CR47","first-page":"771","volume":"17","author":"HC Nossent","year":"1990","unstructured":"Nossent HC, Swaak TJG: Sysyemic lupus erythematosus. VI: Analysis of the interrelationship with pregnancy. J Rheumatol. 1990, 17: 771-776.","journal-title":"J Rheumatol"},{"key":"362_CR48","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0895-4356(99)00050-5","volume":"52","author":"C Van Walraven","year":"1999","unstructured":"Van Walraven C, Mahon JL, Maher D, Bohm C, Loupecis A: Surveying physicians to determine the minimal important difference: implications for sample size calculations. J Clin Epidemiol. 1999, 52: 717-723. 10.1016\/S0895-4356(99)00050-5.","journal-title":"J Clin Epidemiol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-7-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1546-0096-7-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1546-0096-7-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T10:55:15Z","timestamp":1633431315000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/1546-0096-7-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,13]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["362"],"URL":"https:\/\/doi.org\/10.1186\/1546-0096-7-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,13]]},"article-number":"9"}}